marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-14-2024
Forte Biosciences Financial Statements 2011-2024 | FBRX
Annual Financial Statements Forte Biosciences
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
23.3 M | 20.6 M | 29.9 M | 380 M | 154 M | 3.27 B | 2.79 B | - | - | - | - | - | - |
Shares |
36.3 M | 21 M | 14 M | 11.2 M | 1.34 M | 1.34 M | 974 K | - | - | - | - | - | - |
Historical Prices |
0.64 | 0.98 | 2.14 | 36.4 | 8 | 123 | 154 | - | - | - | - | - | - |
Net Income |
-31.5 M | -13.9 M | -21.7 M | -46.5 M | -4.07 M | -49 M | -38.9 M | -33.5 M | -23.1 M | - | - | - | - |
Revenue |
- | - | - | - | - | 18 M | 41 K | 49 K | 51 K | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-32.5 M | -13.9 M | -21.5 M | -46.3 M | -4.06 M | -45.9 M | -37.6 M | -31.7 M | -23 M | - | - | - | - |
Interest Expense |
-114 K | -145 K | -222 K | -205 K | -5 K | - | - | - | - | - | - | - | - |
EBITDA |
-32.5 M | - | -21.4 M | -14.2 M | -4.05 M | -45.2 M | -37.3 M | -31.4 M | -22.7 M | - | - | - | - |
Operating Expenses |
32.5 M | 13.9 M | 21.5 M | 14.2 M | 4.06 M | 63.9 M | 37.7 M | 31.7 M | 23 M | - | - | - | - |
General and Administrative Expenses |
10.6 M | 8.3 M | 7.63 M | 4.22 M | 1.38 M | 12.8 M | 8.56 M | 4.52 M | 3.83 M | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Forte Biosciences
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
1.46 M | 36.4 M | 36.4 M | 1.45 M | 36.3 M | 21 M | 21 M | 21 M | 18.9 M | 14.8 M | 14.8 M | 14.8 M | 14.2 M | 13.6 M | 13.3 M | 12.8 M | 11.2 M | 3.65 M | 2.12 B | 2.11 M | 2.11 B | 2.11 B | 23 M | 23 M | 20 M | 19.9 M | 19.9 M | 19.9 M | 19.8 M | 16.3 M | 2.21 M | 2.2 M | 2.2 M | 2.2 M | 2.2 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-8.39 M | -12.5 M | -7.42 M | - | -9.96 M | -8.9 M | -6.75 M | - | -3.4 M | -3.04 M | -2.57 M | - | -7.75 M | -5.81 M | -4.8 M | - | -5.1 M | -34.8 M | -2.05 M | -10.6 M | -690 K | -630 K | -1.18 M | -19.6 M | -383 K | -16.1 M | -12.9 M | -10.8 M | -9.95 M | -9.07 M | -9.07 M | -8.43 M | -9 M | -8.04 M | -8.01 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9 K | 9 K | 9 K | - | 18 M | 9 K | 9 K | - | 10 K | 10 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-8.63 M | -12.8 M | -7.8 M | - | -10.2 M | -9.03 M | -6.86 M | - | -3.42 M | -3.02 M | -2.51 M | - | -7.7 M | -5.75 M | -4.74 M | - | -5.01 M | -34.8 M | -2.03 M | - | -684 K | -629 K | -16.9 M | - | 1.43 M | -15.3 M | -12.8 M | - | -9.74 M | -8.65 M | -8.55 M | - | -8.53 M | -7.62 M | -7.57 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
237 K | 307 K | 384 K | - | 261 K | 138 K | 102 K | - | 23 K | -15 K | -53 K | - | -52 K | -65 K | -63 K | - | -92 K | -7 K | -23 K | - | -6 K | -1 K | -213 K | - | -301 K | -762 K | -34 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
- | - | -7.8 M | - | - | - | - | - | -3.42 M | -3.02 M | -2.51 M | - | -7.66 M | -5.72 M | -4.73 M | - | -4.97 M | -34.7 M | -2.01 M | - | -684 K | -629 K | -16.7 M | - | 1.85 M | -15.1 M | -12.8 M | - | -9.54 M | -8.52 M | -8.49 M | - | -8.34 M | -7.5 M | -7.51 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
8.63 M | 12.8 M | 7.8 M | - | 10.2 M | 9.03 M | 6.86 M | - | 3.42 M | 3.02 M | 2.51 M | - | 7.7 M | 5.75 M | 4.74 M | - | 5.01 M | 34.8 M | 2.03 M | 10.7 M | 684 K | 629 K | 16.9 M | 19.1 M | 16.6 M | 15.3 M | 12.9 M | 10.7 M | 9.75 M | 8.66 M | 8.56 M | 7.98 M | 8.54 M | 7.63 M | 7.58 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
2.76 M | 7.08 M | 3.45 M | - | 3.85 M | 1.9 M | 2.07 M | - | 2.04 M | 1.99 M | 1.82 M | - | 2.04 M | 2.22 M | 1.42 M | - | 1.32 M | 760 K | 673 K | - | 331 K | 319 K | 4.45 M | - | 4.32 M | 2.57 M | 2.42 M | - | 2.18 M | 2.03 M | 1.94 M | - | 956 K | 1.1 M | 1.11 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency